Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.285 USD | +1.42% |
|
+0.42% | -63.64% |
Jun. 17 | Ladenburg Downgrades Coeptis Therapeutics to Neutral From Buy | MT |
Jun. 14 | Coeptis Therapeutics Holdings, Inc. announced that it has received $4.3 million in funding | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 10.58M |
---|---|---|---|---|---|
Net income 2024 * | -12M | Net income 2025 * | -15M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.1
x | P/E ratio 2025 * |
-1.68
x | Employees | 6 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 74.42% |
1 day | +1.42% | ||
1 week | +0.42% | ||
Current month | -1.38% | ||
1 month | +1.46% | ||
3 months | -18.59% | ||
6 months | -57.46% | ||
Current year | -63.64% |
![Extreme 0.2651](/images/extremecours_fleche.png)
![Extreme 0.2603](/images/extremecours_fleche.png)
![Extreme 0.2303](/images/extremecours_fleche.png)
![Extreme 0.2303](/images/extremecours_fleche.png)
![Extreme 0.2303](/images/extremecours_fleche.png)
![Extreme 0.2303](/images/extremecours_fleche.png)
![Extreme 0.2303](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
David Mehalick
CEO | Chief Executive Officer | 56 | 22-10-27 |
Brian Cogley
DFI | Director of Finance/CFO | 38 | 23-05-16 |
Daniel Yerace
COO | Chief Operating Officer | 41 | 22-10-27 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 62 | 22-10-27 | |
Director/Board Member | 55 | 22-10-27 | |
Christine Sheehy
CMP | Compliance Officer | 57 | 22-10-27 |
Date | Price | Change | Volume |
---|---|---|---|
24-07-08 | 0.285 | +1.42% | 117,708 |
24-07-05 | 0.281 | +1.74% | 113,589 |
24-07-03 | 0.2762 | +0.44% | 33,091 |
24-07-02 | 0.275 | -3.10% | 46,983 |
Delayed Quote Nasdaq, July 08, 2024 at 04:30 pm EDT
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-63.64% | 10.58M | |
+57.48% | 827B | |
-7.18% | 350B | |
+15.37% | 319B | |
+7.45% | 294B | |
+14.21% | 240B | |
+14.82% | 221B | |
+0.12% | 219B | |
+8.14% | 167B | |
-2.99% | 158B |
- Stock Market
- Equities
- COEP Stock